Viewing nowEzetimeb Tablet 10 mg (Ezetimibe)
Ezetimibe 10mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.

MFDS item code 201802161 · Approved 2018.05.24 · Insurance code 662503940
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
This medication helps lower blood cholesterol levels in patients with primary hypercholesterolemia and mixed hyperlipidemia. It particularly reduces total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B levels, and may be used in conjunction with other lipid-lowering agents such as fenofibrate or statins. Additionally, it helps control cholesterol and phytosterol levels when administered alongside dietary therapy in patients with homozygous familial hypercholesterolemia and homozygous sitosterolemia. This medication is recommended to be used together with appropriate dietary therapy and especially when there is insufficient response to other non-drug interventions. Before use, it is important to exclude other causes of dyslipidemia and conduct necessary tests. This medication improves hypercholesterolemia and related blood lipid abnormalities.
Continue a standard cholesterol-lowering diet during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, regardless of meals. When administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate treatment with this medicine alongside the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine concomitantly while maintaining the HMG-CoA reductase inhibitor dose. When this medicine is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160 mg once daily or 200 mg once daily (see Precautions for Use 4. General Precautions). No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use 2. Patients Requiring Caution). No dose adjustment is necessary in patients with renal impairment. No dose adjustment is necessary in older adults. Administer this medicine at least 2 hours before or 4 hours after administration of a bile acid sequestrant (see Precautions for Use 5. Interactions).
This medication should not be used in patients who are allergic to specific components. Patients with active liver disease or consistently elevated liver enzyme levels should not take this medication in conjunction with specific lipid-lowering agents. Pregnant or breastfeeding women should exercise caution as the concomitant use of this medication with specific lipid-lowering agents is prohibited. Patients with moderate to severe liver function impairment may have increased exposure to this medication, leading to unexpected side effects, and therefore should avoid its use. This medication is generally well tolerated, but side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may occur; any unusual symptoms should prompt consultation with a physician. If muscle pain, weakness, or discomfort occurs, immediate notification to healthcare professionals is necessary and discontinuation of the medication may be warranted in severe cases. Regular liver function tests are required, and if liver enzyme levels increase, it may be necessary to adjust the treatment plan. Patients with severely impaired kidney function also require caution, particularly with concurrent use of statins, requiring dosage adjustment and monitoring. This medication may interact with other drugs, so it is essential to inform healthcare providers of any other medications being taken. Pregnant or breastfeeding women must consult a physician before taking this medication, carefully considering potential risks and benefits. It is not recommended for children under 6 years of age, and for those aged 6 and older, it should be administered according to a doctor's instructions. Elderly patients may respond sensitively to this medication and should exercise caution. In case of overdose, there is no specific antidote, and treatment will be symptomatic. This medication should be stored out of the reach of children, and it is safe not to transfer it to other containers.
Fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, chest pain, dizziness, headache, constipation, bloating, nausea, increased AST, increased ALT, myalgia, myopathy, rhabdomyolysis, hepatitis, thrombocytopenia, pancreatitis, sensory disturbances, depression, cholelithiasis, cholecystitis, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanying drug reactions, erythema multiforme, drug-induced liver injury, chest discomfort, swelling, asthenia, generalized edema, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, dry mouth, discomfort in the epigastrium, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, diabetes mellitus, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival congestion, renal failure, liver dysfunction, increased serum creatine phosphokinase, abnormal liver function tests, nausea
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain a temperature between 1 and 30 degrees Celsius to preserve the medication's efficacy.
White to off-white rectangular tablet
10 tablets/PTP, 100 tablets/bottle, 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEzetimibe 10mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Shin Il Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.